Home533573 • BOM
add
Alembic Pharmaceuticals Ltd
Previous close
₹900.70
Day range
₹891.00 - ₹903.85
Year range
₹725.60 - ₹1,152.60
Market cap
176.72B INR
Avg Volume
16.67K
P/E ratio
29.30
Dividend yield
1.22%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 17.11B | 9.54% |
Operating expense | 10.96B | 9.59% |
Net income | 1.54B | 14.60% |
Net profit margin | 9.02 | 4.52% |
Earnings per share | 7.85 | 14.77% |
EBITDA | 2.72B | 17.86% |
Effective tax rate | 19.19% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 834.80M | -30.55% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 51.90B | — |
Shares outstanding | 196.66M | — |
Price to book | 3.41 | — |
Return on assets | — | — |
Return on capital | 8.05% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 1.54B | 14.60% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1907
Employees
16,571
